Sugi Predict

Sugi Predict / Compounds / SCHEMBL20437178

SCHEMBL20437178

SCHEMBL20437178

COC(=O)[C@H](Cc1ccc(Oc2ccnc3c2c(C)cn3S(=O)(=O)c2ccc(C)cc2)cc1)N(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.34
▸ PTGER1 P34995 1/20 0.33
▸ ITGB3 P05106 2/20 0.33
▸ ITGAV P06756 2/20 0.33
▸ P2RX3 P56373 1/20 0.33
▸ ITGB1 P05556 1/20 0.33
▸ ITGA5 P08648 1/20 0.33
▸ ALOX5 P09917 3/20 0.32
▸ P2RX7 Q99572 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ HTR6 P50406 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PDGFRA P16234 1/20 0.31
▸ KDR P35968 1/20 0.31
▸ GRM4 Q14833 1/20 0.31
▸ EGFR P00533 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20422592 0.92 PPARG (0.36) ITGB3ITGAVP2RX3ITGB1ITGA5
SCHEMBL20422591 0.92 PPARG (0.36) ITGB3ITGAVP2RX3ITGB1ITGA5
SCHEMBL20437176 0.88 PTGS2 (0.39) PKMITGB3ITGAVP2RX3ITGB1
SCHEMBL20422482 0.86 L3MBTL1 (0.38) PKMITGB3ITGAVP2RX3ITGB1
SCHEMBL20422385 0.83 TPH1 (0.37) ITGB3ITGAVITGB1ITGA5L3MBTL1
SCHEMBL20422383 0.83 TPH1 (0.37) ITGB3ITGAVITGB1ITGA5L3MBTL1
SCHEMBL20439550 0.83 P2RX3 (0.31) P2RX3L3MBTL1KMT2APDGFRAKDR
SCHEMBL20437150 0.83 BCL2 (0.40) ITGB3ALOX5P2RX7MEN1KMT2A
SCHEMBL20437152 0.83 BCL2 (0.40) ITGB3ALOX5P2RX7MEN1KMT2A
SCHEMBL23072668 0.82 TDP1 (0.44) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10954236-B2 Tyrosine amide derivatives as Rho-Kinase inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2021-03-23 — — US disclosed
EP-3573987-B1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARM SPA (IT) 2021-03-10 — — EP disclosed
US-20180215758-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2018-08-02 — — US disclosed
US-20180215758-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2018-08-02 — — US disclosed
WO-2018138293-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2018-08-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10954236-B2 Tyrosine amide derivatives as Rho-Kinase inhibitors ROCK1, ROCK2, CIT PKM 1213/4885PTGER1 514/4885ITGB3 2624/4885
US-20180215758-A1 TYROSINE AMIDE DERIVATIVES AS RHO- KINASE INHIBITORS ROCK1, ROCK2, CIT PKM 1213/4885PTGER1 514/4885ITGB3 2624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.